In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
about
Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia speciesMalassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine.In vitro amphotericin B susceptibility of Malassezia pachydermatis determined by the CLSI broth microdilution method and Etest using lipid-enriched media.Voriconazole in the management of nosocomial invasive fungal infections.A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation.Update on the genus Malassezia.Malassezia pachydermatis fungemia in an adult with multibacillary leprosy.CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazoleNew and investigational triazole agents for the treatment of invasive fungal infections.Efficacy of albaconazole against Candida albicans in a vaginitis model.New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.Pharmacology and clinical use of voriconazole.A modified Christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole.Malassezia species in healthy skin and in dermatological conditions.Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and EtestA randomized, double-blind, multiple-dose, placebo-controlled, dose escalation study with a 3-cohort parallel group design to investigate the tolerability and pharmacokinetics of albaconazole in healthy subjects.Ketoconazole inhibits Malassezia furfur morphogenesis in vitro under filamentation optimized conditions.A randomized double-blind, non-inferiority Phase II trial, comparing dapaconazole tosylate 2% cream with ketoconazole 2% cream in the treatment of Pityriasis versicolor.Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.Antimycotics suppress the Malassezia extract-induced production of CXC chemokine ligand 10 in human keratinocytes.In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.Newer antifungal agents.Methodological Issues in Antifungal Susceptibility Testing of Malassezia pachydermatis.Assessment of in vitro inhibitory activity of hydrogen peroxide on the growth of Malassezia pachydermatis and to compare its efficacy with commercial ear cleaners.
P2860
Q28769637-ADCBFC0F-20D3-42F1-B69A-AEDB81BE1CEEQ33736875-C2200C55-9D98-4220-933C-A0145E67D52CQ33798294-6B5B36CA-2C21-4831-B7F6-46C27116DD6CQ35166823-988E58C4-7FFC-4D8E-8275-6E90615A7E62Q36587695-6F09090C-A9A3-4758-9C85-B027259E2D1CQ36825709-39508001-B197-4B86-8573-4B68F2D5E1E4Q37011115-AE2B58FD-3EC7-4557-8611-297879D2EC8BQ37162049-08DC3819-0404-4819-8464-695C84830054Q37364295-A169D66B-9383-4451-A44A-765DF0E87FB3Q37392798-DC5E941F-DB5A-4C57-ADF7-FEA0C7EF33E3Q37608276-CDF41E17-B236-4B3F-8D49-86A852E3432EQ37641375-ABFE16F7-B31B-4CBE-ADF6-8B9BCADF80B7Q38476366-06A48D84-DAB9-468A-9F83-A3FAFA61BB03Q38681469-BBCF402B-8617-499A-AF96-417C5F5D119CQ39393643-B1EB8F34-3FBE-4918-A643-37179E2BBE91Q39485643-8A0CF1B1-78B0-410B-AE1E-515ED9A2DC3EQ39810673-74D0F272-9499-49B5-B31D-4E99E40DD4A6Q40436517-230158D5-4208-4C82-80D2-A588824EF256Q40975087-5C2899AC-D61E-4E1E-A652-4248DDDAA283Q41126248-177D6B37-52A0-48F8-9931-976585221F1FQ42707137-ED279F32-4B4D-4B77-AAAC-D66D87B2BB3AQ44539867-257C529C-3356-4B6B-86A0-162272F0AC2AQ44729371-AB8CEFEF-B767-42A3-B789-C915A095D2CBQ44855715-F6DB0E46-1219-4B64-B135-7E435BE5D459Q47711304-6B2330F9-55B8-4571-A2CE-AF8391A6E0CEQ48360323-86C54A69-689A-4893-B7BA-C5965193A8DB
P2860
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
In vitro susceptibilities of M ...... nd other antifungal compounds.
@ast
In vitro susceptibilities of M ...... nd other antifungal compounds.
@en
type
label
In vitro susceptibilities of M ...... nd other antifungal compounds.
@ast
In vitro susceptibilities of M ...... nd other antifungal compounds.
@en
prefLabel
In vitro susceptibilities of M ...... nd other antifungal compounds.
@ast
In vitro susceptibilities of M ...... nd other antifungal compounds.
@en
P2860
P1476
In vitro susceptibilities of M ...... and other antifungal compounds
@en
P2093
Amalia del Palacio
Margarita Garau
P2860
P304
P356
10.1128/AAC.47.7.2342-2344.2003
P407
P50
P577
2003-07-01T00:00:00Z